Abstract |
Spinocerebellar ataxia type 2 (SCA2) is caused by mutations in the ATXN2 gene in which toxic effects are triggered by expanded polyglutamine repeats within ataxin-2. SCA2 is accompanied by motor neuron degeneration as occurs in amyotrophic lateral sclerosis (ALS). We investigated the distribution patterns of ataxin-2 and transactivation-responsive DNA-binding protein 43 (TDP-43), a major disease-related protein in ALS, in the CNS of 3 SCA2 patients. Phosphorylated TDP-43 (pTDP-43)-positive lesions were widely distributed throughout the CNS and generally overlapped with 1C2 (expanded polyglutamine)-immunoreactive lesions. This distribution pattern is different from the pattern in limbic-predominant age-related TDP-43 encephalopathy. In SCA2, double immunostaining of TDP-43 and 1C2 in motor neurons revealed 3 staining patterns: cytoplasmic 1C2 and nuclear TDP-43, nucleocytoplasmic 1C2 and nuclear TDP-43, and nuclear 1C2 and cytoplasmic TDP-43, which reflect the early, active, and final stages of pathological change, respectively. The translocation of TDP-43 from the nucleus to the cytoplasm along with the translocation of 1C2 in the opposite direction indicates that nuclear accumulation of the disease-specific protein ataxin-2 affects the intracellular dynamics of TDP-43. Such a close interrelationship between mutant ataxin-2 and TDP-43 in the cell might account for the similarity of their distribution in the CNS of patients with SCA2.
|
Authors | Shigeru Koyano, Saburo Yagishita, Mikiko Tada, Hiroshi Doi, Toshiki Uchihara, Fumiaki Tanaka |
Journal | Journal of neuropathology and experimental neurology
(J Neuropathol Exp Neurol)
Vol. 81
Issue 7
Pg. 535-544
(06 20 2022)
ISSN: 1554-6578 [Electronic] England |
PMID | 35511239
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022 American Association of Neuropathologists, Inc. All rights reserved. |
Chemical References |
- Ataxin-2
- DNA-Binding Proteins
- Peptides
- TARDBP protein, human
- polyglutamine
|
Topics |
- Ataxin-2
(genetics, metabolism)
- Brain
(pathology)
- DNA-Binding Proteins
(genetics, metabolism)
- Humans
- Peptides
- Spinocerebellar Ataxias
(genetics, pathology)
- Transcriptional Activation
(genetics)
|